Stonebridge Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,038
| Closed | -$94.4K | – | 628 |
|
|
2023
Q3 | $94.4K | Sell |
1,038
-10
| -1% | -$909 | 0.01% | 278 |
|
|
2023
Q2 | $84.8K | Buy |
1,048
+550
| +110% | +$44.5K | 0.01% | 286 |
|
|
2023
Q1 | $39.6K | Buy |
498
+110
| +28% | +$8.76K | ﹤0.01% | 394 |
|
|
2022
Q4 | $26.3K | Buy |
388
+10
| +3% | +$677 | ﹤0.01% | 447 |
|
|
2022
Q3 | $19K | Buy |
378
+72
| +24% | +$3.62K | ﹤0.01% | 480 |
|
|
2022
Q2 | $17K | Hold |
306
| – | – | ﹤0.01% | 518 |
|
|
2022
Q1 | $17K | Hold |
306
| – | – | ﹤0.01% | 559 |
|
|
2021
Q4 | $17K | Hold |
306
| – | – | ﹤0.01% | 539 |
|
|
2021
Q3 | $15K | Sell |
306
-306
| -50% | -$15K | ﹤0.01% | 552 |
|
|
2021
Q2 | $23K | Buy |
612
+306
| +100% | +$11.5K | ﹤0.01% | 593 |
|
|
2021
Q1 | $10K | Buy |
+306
| New | +$10K | ﹤0.01% | 635 |
|
|
2020
Q3 | – | Sell |
-250
| Closed | -$8K | – | 537 |
|
|
2020
Q2 | $8K | Hold |
250
| – | – | ﹤0.01% | 522 |
|
|
2020
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 508 |
|
|
2019
Q4 | $7K | Sell |
250
-92
| -27% | -$2.58K | ﹤0.01% | 599 |
|
|
2019
Q3 | $9K | Hold |
342
| – | – | ﹤0.01% | 565 |
|
|
2019
Q2 | $9K | Buy |
+342
| New | +$9K | ﹤0.01% | 591 |
|